Regulation of p53-, Bcl-2- and caspase-dependent signaling pathway in xanthorrhizol-induced apoptosis of HepG2 hepatoma cells

Anticancer Research

Volumn 27, Issue 2, 2007, Pages 965-971

  Handayani, Tri ^a   Sakinah, Sharifah ^a   Nallappan, Meenakshii ^a   Pihie, Azimahtol Hawariah Lope ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

Antiproliferative effect; Apoptosis; Bax; Bcl 2; Caspase 3; Caspase 9; Curcuma xanthorrhiza; HepG2; p53; Xanthorrhizol

Indexed keywords

CASPASE; DNA FRAGMENT; METHYLENE BLUE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; SESQUITERPENOID; UNCLASSIFIED DRUG; XANTHORRHIZOL;

APOPTOSIS; ARTICLE; CANCER GROWTH; CELL ELONGATION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; GENE CONTROL; HUMAN; HUMAN CELL; IC 50; LAMELLIPODIUM; LIVER CELL CARCINOMA; NECROSIS; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STAINING;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, HEPATOCELLULAR; CASPASES; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; ENZYME ACTIVATION; HUMANS; LIVER NEOPLASMS; PHENOLS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; VERO CELLS;

EID: 34247155896     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Parkin MD, Bray F, Ferlay J and Pisani P: Global Cancer Statistic 2002. CA Cancer J Clin 55: 74-108, 2005.
2. National Cancer Registry: Second Report of the National Cancer Registry on Cancer Incidence in Malaysia 2003. Malaysia, Ministry of Health, 2004.
3. Dominguez-Malagon H and Gaytan-Graham S: Hepatocellular carcinoma: an update. Ultrastruct Pathol 25: 497-516, 2001.
4. Pezzuto JM: Plant-derived anticancer agents. Biochem Pharm 53: 121-133, 1997.
5. van Steenis-Kruseman MJ: Curcuma xanthorrhiza Roxb. In: Select Indonesian Medicinal Plants. Jakarta, pp. 18-50, 1953.
6. Jansen PCM: Curcuma xanthorrhiza Roxburgh. In: Plant Resources of South-East Asia: Plants Yielding Non-seed Carbohydrates. Bogor, pp. 74-76, 1996.
7. Perry LM and Metzger J: Medicinal Plants of East and Southeast Asia. London, MIT Press, pp. 18-26, 1980.
8. Ochse JJ and Bakhuizen van Den Brink RC: Vegetables of the Dutch East Indies (Edible Tubers, Bulbs, Rhizomes and Spices Included): Survey of the Indigenous and Foreign Plants Serving, as Pot-herbs and Side-dishes. Archipel Drukkerij Buitenzorg, pp. 231-250, 1931.
9. Dharma AP: Indonesian Medicinal Plants. Jakarta, Balai Pustaka, pp. 27-42, 1987.
10. Yasni S: Effects of Curcuma xanthorrhiza Roxb. and curcuminoids on the level of serum and liver lipids, serum apolipoprotein A-I and lipogenic enzymes in rats. Food Chem Toxicol 31(3): 213-218, 1993.
11. Subanu NP: Curcuma xanthorrhiza Roxb. In: Tinjauan Hasil Penelitian Tanaman Obat di Berbagai Institusi Part I. Jakarta, Ministry of Health of Republic of Indonesia, pp. 118-123, 1991.
12. Dzulkarnain B: Curcuma xanthorrhiza Roxb. In: Tinjauan Hasil Penelitian Tanaman Obat di Berbagai Institusi Part II. Jakarta, Ministry of Health of Republic of Indonesia, pp. 46-52, 1995.
13. Claeson P: Three non-phenolic diarylheptanoids with anti-inflammatory activity from Curcuma xanthorrhiza. Planta Med 59(5): 451-454, 1993.
14. Malingre TM: Curcuma xanthorrhiza, temoe lawak, a plant with cholagog activity. Pharm Weekbl Sci 110: 601-610, 1975.
15. Hirschhorn HH: Botanical remedies of the former Dutch East Indies (Indonesia). I: Eumycetes, Pteridophyta, Gymnospermae, Angiospermae (Monocotylendones only). J Ethnopharmacol 7(2): 123-156, 1983.
16. Ozaki Y and Liang OB: Cholagogic action of the essential oil obtained from Curcuma xanthorrhiza Roxb. Shoyakugaku Zasshi 42(4): 257-263, 1988.
17. Gimlette JD: A Dictionary of Malayan Medicine. New York, Oxford University Press, pp. 66-73, 1939.
18. Saha JC, Savini EC and Kasinathan S: Ecbolic properties of Indian medicinal plants, Part 1. Indian J Med Res 49: 130-151, 1961.
19. Afifah E: Khasiat dan Manfaat Temulawak Rimpang Penyembuh Aneka Penyakit. Jakarta, Agromedia Pustaka, pp. 23-28, 2004.
20. Yasni S: Identification of an active principle in essential oils and hexane-soluble fractions of Curcuma xanthorrhiza Roxb. showing triglyceride-lowering action in rats. Food Chem Toxicol 32(3): 273-278, 1994.
21. Yamazaki M: Studies on pharmacologically active principles from Indonesian crude drugs. I. Principle prolonging pentobarbital-induced sleeping time from Curcuma xanthorrhiza Roxb. Chem Pharm Bull 36(6): 2070-2074, 1988.
22. Czygan FC: Herbal drugs and phytopharmaceuticals. In: A Handbook for Practice on a Scientific Basis. Wichtl M and Bisset NG (eds.). Stuttgart, Medpharm Scientific Publishers, pp. 83-94, 1994.
23. Itokawa H, Hirayama F, Funakashi K and Takeya K: Studies on the antitumor Bisabalone sesquiterpenoids isolated from Curcuma xanthorrhiza. Chem Pharm Bull 33(8): 3488-3492, 1985.
24. Uehara S: Terpenoids and curcuminoids of the rhizoma of Curcuma xanthorrhiza Roxb. Shoyakugaku Zasshi 112(11): 817-823, 1992.
25. Yasni S, Imaizumi K and Sugano M: Effects of an Indonesian medicinal plant, Curcuma xanthorrhiza Roxb., on the levels of serum glucose and triglyceride, fatty acid desaturation, and bile acid excretion in streptozotocin-induced diabetic rats. Agric Biol Chem 55(12): 3005-3010, 1991.
26. Karig F: Rapid identification of Curcuma rhizomes with the TAS (Thermomicroseparation and Application) Process. Dtsch Apoth Ztg 115: 325-328, 1975.
27. Widowati L: Curcuma xanthorrhiza Roxb. In: Tinjauan Hasil Penelitian Tanaman Obat di Berbagai Institusi Part III. Jakarta, Ministry of Health of Republic of Indonesia, pp. 34-39, 1996.
28. Noor KM: Pemeriksaan kuantitatif xanthorrhizol dalam umbi Curcuma xanthorrhiza Roxb. yang berumur 10, 12 dan 29 bulan secara spektrofotometri. skripsi Jurusan Farmasi FMIPA, Institut Teknologi Bandung. In: Tinjauan Hasil Penelitian Tanaman Obat di Berbagai Institusi Part I. Jakarta, Ministry of Health of Republic of Indonesia, pp. 93-110, 1979.
29. Rimpler H, Hansel R and Kochendoerfer L: Xanthorrhizol, a new sesquiterpene from Curcuma xanthorrhiza. Z Naturforsch B: Chem Sci 25(9): 995-998, 1970.
30. Pandji C, Grimm C, Mray V, Witte L and Proksch P: Insecticidal constituents from four species of the Zingiberaceae. Phytochemistry 34: 415-419, 1993.
31. Hasnah MS and Lee LM: Analysis of the essential oils of two Curcuma species. Malays J Anal Sci 8(1): 41-43, 2004.
32. Park JH, Kim JH, Park KK, Kim HO, Hwang JK and Chung WY: Chemopreventive effect of xanthorrhizol from Curcuma xanthorrhiza. J Korean Assoc Cancer Prev 8(2): 91-97, 2003.
33. Lim CS, Jin DQ, Mok H, Oh SJ, Lee JU, Hwang JK, Ha I and Han JS: Antioxidant and antiinflamatory activities of xanthorrhizol in hippocampal neurons and primary cultured microglia. J Neurosci Res 82(6): 881-838, 2005.
34. Hwang JK, Shim JS and Pyun YR: Antibacterial activity of xanthorrhizol from Curcuma xanthorrhiza against oral pathogens. Fitoterapia 71: 321-323, 2000.
35. Hwang JK, Shim JS, Baek NI and Pyun YR: Xanthorrhizol: a potential antibacterial agent from Curcuma xanthorrhiza against Streptococcus mutans. Planta Med 66: 196-197, 2000.
36. Kim SH, Hong KO, Chung WY, Hwang JK and Park KK: Abrogation of cisplatin-induced hepatotoxicity in mice by xanthorrhizol is related to its effect on the regulation of gene transcription. Toxicol Appl Pharmacol 196: 346-355, 2004.
37. Kim SH, Hong KO, Hwang JK and Park KK: Xanthorrhizol has a potential to attenuate the high dose cisplatin-induced nephrotoxicity in mice. Food Chem Toxicol 43: 117-122, 2005.
38. Lin SC: Protective and therapeutic effects of Curcuma xanthorrhiza on hepatotoxin-induced liver damage. Am J Chin Med 23(3-4): 243-254, 1995.
39. Yasni S: Effects of Curcuma xanthorrhiza Roxb. and curcuminoids on the level of serum and liver lipids, serum apolipoprotein A-I and lipogenic enzymes in rats. Food Chem Toxicol 31(3): 213-218, 1993.
40. Siti Farah M, Halimah AS and Azimahtol Hawariah LP: Potensi xanthorrhizol sebagai agen antitumor kulit. In: Prosiding Kolokium Siswazah Kelima Fakulti Sains dan Teknologi. Malaysia, National University of Malaysia, pp. 22-24, 2005.
41. Choi MA, Kim SH, Chung WY, Hwang JK and Park KK: Xanthorrhizol, a natural sesquiterpenoid from Curcuma xanthorrhiza, has an anti-metastatic potential in experimental mouse lung metastasis model. Biochem Biophys Res Commun 326: 210-217, 2005.
42. Norzila I, Azimahtol Hawariah LP and Meenakshii N: Xanthorrhizol induces apoptosis via the up-regulation of bax and p53 in HeLa cells. Anticancer Res 25(3B): 2221-2227, 2005.
43. Lin L and Hwang PL: Antiproliferative effects of oxygenated sterols: positive correlation with binding affinities for the antiestrogen binding sites. Biochim Biophys Acta 1082: 177-184, 1991.
44. Zhou JM, Zhu XF, Pan QC, Liao DF, Li ZM and Liu ZC: Manumycin induces apoptosis in human hepatocellular carcinoma HepG2 cells. Int J Mol Med 12: 955-959, 2003.
45. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantitites of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
46. Jans DA, Sutton VR, Jans P, Froelich CJ and Trapani JA: BCL-2 blocks perforin-induced nuclear translocation of granzymes concomitant with protection against the nuclear events of apoptosis. J Biol Chem 274: 3953-3961, 1999.
47. Oltvai ZN, Milliman CL and Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619, 1993.
48. Budihardjo I, Oliver H, Lutter M, Luo X and Wang X: Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 15: 269-290, 1999.
49. Thornberry NA and Lazebnik Y: Caspases: enemies within. Science 281: 1312-1316, 1998.
50. Lowe SW and Lin AW: Apoptosis in cancer. Carcinogenesis 21: 485-495, 2000.
51. Bold RJ, Termuhlen PM and McConkey DJ: Apoptosis, cancer and cancer therapy. Surg Oncol 6: 133-142, 1997.
52. Kauffman SH and Earnshaw WC: Induction of apoptosis by cancer chemotherapy. Exp Cell Res 256: 42-49, 2000.
53. Reed JC: Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies. Semin Hematol 34: 9-19, 1997.
54. Herr I and Debatin KM: Cellular stress response and apoptosis in cancer therapy. Blood 98: 2603-2614, 2001.
55. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 26: 1456-1462, 1995.
56. Cory S, Huang DC and Adams JM: The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22: 8590-8607, 2003.
57. Hou Q, Cymbalyuk E, Hsu HC, Xu M and Hsu YT: Apoptosis modulatory activities of transiently expressed Bcl-2: roles in cytochrome c release and Bax regulation. Apoptosis 8: 617-629, 2003.
58. Degli Esposti M and Dive C: Mitochondrial membrane permeabilisation by Bax/Bak. Biochem Biophys Res Commun 304: 455-461, 2003.
59. Yang J, Liu X, Bhalla K, Kim C, Ibrado A, Cai J, Peng TI, Jones D and Wang X: Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275: 1129-1132, 1997.
60. Kluck RM, Bossy-Wetzel E, Green DR and Newmeyer DD: The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136, 1997.
61. Teoh PL and Azimahtol Hawariah LP: Effects of styrylpyrone derivative (SPD) on expression of Bcl-2 and Bax genes in human ovarian carcinoma cell line, Caov-3. Malays Appl Biol 28: 107-111, 1999.
62. Gross A, McDonnell JM and Korsmeyer SJ: Bcl-2 family members and the mitochondria in apoptosis. Genes Dev 13: 1899-1911, 1999.
63. Vander Heiden MG and Thompson CB: Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? Nat Cell Biol 1: E209-E216, 1999.
64. Zhang L, Yu J, Park BH, Kinzler KW and Vogelstein B: Role of Bax in the apoptotic response to anticancer agents. Science 290: 989-992, 2000.
65. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B and Reed JC: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805, 1994.
66. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wang X: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489, 1997.
67. Srinivasula SM, Ahmad M, Fernandes-Alnemri T and Alnemri ES: Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol Cell 1: 949-957, 1998.
68. Talanian RV, Quinlan C, Trautz S, Hackett MC, Mankovich JA, Banach D, Ghayur T, Brady KD and Wong WW: Substrate specificities of caspase family proteases. J Biol Chem 272: 9677-9682, 1997.
69. Woo M, Hakem R, Soengas MS, Duncan GS, Shahinian A, Kagi D, Hakem A, McCurrah M, Khoo W, Kaufman SA, Senaldi G, Howard T, Lowe SW and Mak TW: Essential contribution of caspase-3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev 12: 806-819, 1998.
70. Shi YA: A structural view of mitochondria-mediated apoptosis. Nat Struct Biol 8: 394-401, 2001.
71. Robertson JD and Orrenius S: Molecular mechanisms of apoptosis induced by cytotoxic chemicals. Crit Rev Toxicol 30: 609-627, 2000.